Recent News

• 04.02.2025 - Enliven Therapeutics Announces Poster Presentations at the 2025 AACR Annual Meeting
• 04.02.2025 - Enliven Therapeutics Announces Poster Presentations at the 2025 AACR Annual Meeting
• 03.13.2025 - Enliven Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update
• 03.13.2025 - Enliven Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update

Recent Filings

• 03.31.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.27.2025 - 144 Report of proposed sale of securities
• 03.26.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.21.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.19.2025 - 144 Report of proposed sale of securities
• 03.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.18.2025 - 144/A Report of proposed sale of securities
• 03.18.2025 - 144 Report of proposed sale of securities
• 03.18.2025 - 144/A Report of proposed sale of securities
• 03.18.2025 - 144 Report of proposed sale of securities